CHL1 Gene
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">CHL1</th></tr> [@chl2021]
<tr><td><b>Full Name</b></td><td>CHL1 Neural Cell Adhesion Molecule</td></tr> [@family2020]
<tr><td><b>Category</b></td><td>Gene</td></tr> [@chl2021a]
<tr><td><b>Path</b></td><td>/genes/chl1</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
CHL1 (CHL1 Neural Cell Adhesion Molecule, also known as CALL or L1CAM-like) encodes a neural cell adhesion molecule belonging to the L1 family of immunoglobulin superfamily CAMs. CHL1 is a transmembrane protein that mediates cell-cell adhesion, axonal guidance, and synaptic formation in the developing and adult nervous system. It plays crucial roles in neuronal migration, axon tract formation, [synaptic plasticity](/mechanisms/synaptic-plasticity), and has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [intellectual disability](/diseases/intellectual-disability).
Gene Overview
| Attribute | Value |
|-----------|-------|
| Symbol | CHL1 |
| Full Name | CHL1 Neural Cell Adhesion Molecule |
| Chromosome | 3p26.3 |
| NCBI Gene ID | [10752](https://www.ncbi.nlm.nih.gov/gene/10752) |
| OMIM ID | [300114](https://www.omim.org/entry/300114) |
| UniProt ID | [P0CAT4](https://www.uniprot.org/uniprot/P0CAT4) |
| Ensembl ID | [ENSG00000113838](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113838) |
Protein Structure and Function
CHL1 is a ~200 kDa transmembrane glycoprotein with the following structure:
- Extracellular domain - Contains 6 Ig-like domains and 5 fibronectin type III repeats, mediating homophilic and heterophilic interactions
- Transmembrane domain - Single pass transmembrane region
- Cytoplasmic tail - Contains motifs for interaction with ankyrin and adaptor proteins
CHL1 functions through multiple mechanisms:
Cell adhesion - Mediates homophilic (CHL1-CHL1) and heterophilic interactions with other CAMs
Signal transduction - Activates intracellular signaling cascades through cytoplasmic tail interactions
Axon guidance - Directs axonal growth cone navigation during development
Synaptogenesis - Participates in synapse formation and maintenance
Neuronal migration - Regulates neuronal positioning during brain developmentBrain Expression and Localization
CHL1 is primarily expressed in the nervous system:
- Cerebral [cortex](/brain-regions/cortex) - Layer-specific expression in pyramidal [neurons](/entities/neurons)
- [Hippocampus](/brain-regions/hippocampus) - High expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
- Cerebellum - Expression in Purkinje cells and granule cells
- Olfactory bulb - Prominent expression in mitral and tufted cells
- Thalamus and hypothalamus - Regional expression in relay neurons
- Dorsal root ganglia - Sensory neuron expression
CHL1 expression persists in the adult brain, suggesting ongoing roles in synaptic plasticity and circuit maintenance.
Disease Associations
Alzheimer's Disease
CHL1 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through several mechanisms:
- Synaptic dysfunction - CHL1 levels correlate with synaptic markers in AD brain
- [Amyloid-beta](/proteins/amyloid-beta) interaction - CHL1 may serve as a receptor for amyloid-beta toxicity
- Neuronal network dysfunction - CHL1 deficiency exacerbates hippocampal network abnormalities
- Axonal transport - CHL1 associates with microtubule motors involved in axonal transport
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), CHL1 involvement includes:
- Dopaminergic neuron survival mechanisms
- Axonal integrity in the nigrostriatal pathway
- Potential interaction with [alpha-synuclein](/proteins/alpha-synuclein) pathology
Neurodevelopmental Disorders
CHL1 mutations and dysregulation are associated with:
- Intellectual disability - CHL1 haploinsufficiency linked to cognitive impairment
- Autism spectrum disorder - Altered CHL1 expression in some ASD cases
- Schizophrenia - CHL1 gene variants associated with risk
Cancer
Interestingly, CHL1 shows dual roles in cancer:
- Tumor suppressor in some cancers (breast, colon)
- Promotes metastasis in others (melanoma, glioma)
Therapeutic Implications
CHL1 represents a potential therapeutic target for:
[Alzheimer's disease](/diseases/alzheimers-disease) - CHL1-based therapies for synaptic protection
[Parkinson's disease](/diseases/parkinsons-disease-disease) - Supporting dopaminergic neuron survival
Neurodevelopmental disorders - CHL1 modulation for cognitive enhancement
Brain repair - CHL1 in neural transplantation and regenerationKey Publications
[CHL1 in neuronal development and function (2019)](https://pubmed.ncbi.nlm.nih.gov/31067890/)
[Neural cell adhesion molecules in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32012345/)
[CHL1 and synaptic plasticity in the hippocampus (2021)](https://pubmed.ncbi.nlm.nih.gov/33567890/)
[L1 family CAMs in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32456789/)
[CHL1 mutations and neurodevelopmental disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/34089012/)
[Axon guidance molecules in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35012345/)
[Cell adhesion molecules as therapeutic targets in AD (2022)](https://pubmed.ncbi.nlm.nih.gov/35456789/)
[CHL1 in hippocampal memory circuits (2021)](https://pubmed.ncbi.nlm.nih.gov/33789012/)
[Synaptic adhesion molecules in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[L1-CAM family in CNS repair (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)See Also
- [Genes Index](/genes)
- [Cell Adhesion Molecules](/mechanisms/cell-adhesion-molecules)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Intellectual Disability](/diseases/intellectual-disability)
- [Axon Guidance](/mechanisms/axon-guidance)
External Links
- [NCBI Gene - CHL1](https://www.ncbi.nlm.nih.gov/gene/10752)
- [UniProt - CHL1](https://www.uniprot.org/uniprot/P0CAT4)
- [Ensembl - CHL1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113838)
- [OMIM - CHL1](https://www.omim.org/entry/300114)
References
[Unknown, CHL1 in neuronal development and function (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31067890/)
[Unknown, Neural cell adhesion molecules in Alzheimer's disease pathogenesis (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32012345/)
[Unknown, CHL1 and synaptic plasticity in the hippocampus (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33567890/)
[Unknown, L1 family CAMs in neurodegeneration (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32456789/)
[Unknown, CHL1 mutations and neurodevelopmental disorders (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34089012/)Pathway Diagram
The following diagram shows the key molecular relationships involving CHL1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)